Some pharmaceutical companies not targeted by President Trump for agreements to lower U.S. drug pricing aim to craft their ...
Vinay Prasad is tightening the screws at the FDA, overruling staff and signaling a tougher stance on vaccines and gene ...
Today, we’ve got a ton of updates including news about venture capital funding, telehealth policy, the government’s progress ...
BridgeBio Pharma’s experimental drug for the most common cause of dwarfism accelerated children’s growth in a pivotal ...
Digital therapeutics developer Big Health announced Thursday that it has raised $23.7 million from notable investors betting ...
Talkiatry, a virtual psychiatry company, announced Thursday it raised $210 million as it looks to build on its ...
Prasad changed jobs but his conservative regulatory doctrine remains the same, particularly for cell and gene therapies. The ...
To reduce heart disease risk, it's the quality, not the quantity, of carbs or fats that matter, says new study from the ...
The director-general of the WHO said a U.S.-funded study of the hepatitis B vaccine in Guinea-Bissau would be “unethical” if ...
The rejection is the latest instance of Vinay Prasad overruling career FDA scientists to place vaccines under harsher ...
Advocacy groups from 30 countries are urging Merck to create a global access strategy for its once-a-month HIV prevention ...
New questions about lung cancer in ‘never-smokers’ As the number of people who smoke has gone down over the decades, those who never smoked have begun to make up a greater proportion of lung cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results